Tokyo startup confirms efficacy of iPS cell-derived heart muscle transplantsby Asia Today Team December 13, 2025 0 A medical trial by a Tokyo-based enterprise firm originating from Keio College has confirmed that transplanting cardiac muscle cell clusters ...